Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de-escalating approach.
van Steenhoven JEC, van Maaren MC, Verreck EEF, Schipper RJ, Nieuwenhuijzen GAP, Kuijer A, Siesling S, van Dalen T. van Steenhoven JEC, et al. Int J Cancer. 2023 Apr 1;152(7):1378-1387. doi: 10.1002/ijc.34400. Epub 2022 Dec 27. Int J Cancer. 2023. PMID: 36522834 Free PMC article.
Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict.
van Steenhoven JEC, den Dekker BM, Kuijer A, van Diest PJ, Nieboer P, Zuetenhorst JM, Imholz ALT, Siesling S, van Dalen T. van Steenhoven JEC, et al. Breast Cancer Res Treat. 2020 Jul;182(1):107-115. doi: 10.1007/s10549-020-05683-6. Epub 2020 May 19. Breast Cancer Res Treat. 2020. PMID: 32430679 Free PMC article.
Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
Roos MM, van Steenhoven JEC, Aalders KC, Schreuder K, Burgmans JPJ, Siesling S, Elias S, van Dalen T. Roos MM, et al. Among authors: van steenhoven jec. Ann Surg Oncol. 2019 Feb;26(2):372-378. doi: 10.1245/s10434-018-6940-5. Epub 2018 Nov 1. Ann Surg Oncol. 2019. PMID: 30387028
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
van Steenhoven JEC, Kuijer A, van Diest PJ, van Gorp JM, Straver M, Elias SG, Wesseling J, Rutgers E, Timmer-Bonte JNH, Nieboer P, Smilde TJ, Imholz A, Blanken CFJM, Siesling S, van Dalen T. van Steenhoven JEC, et al. Genes (Basel). 2018 May 17;9(5):261. doi: 10.3390/genes9050261. Genes (Basel). 2018. PMID: 29772837 Free PMC article.